Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial
NCT06907173Phase 3Recruiting
- Sponsor
- University of Virginia
- Start
- Mar 2026
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in status epilepticus (SE), sponsored by University of Virginia. Started Mar 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT06907173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907173.